Abstract
The Wnt signaling pathway is implicated in a variety of biological processes ranging from developmental cell fate to human disease. The components involved in Wnt signaling have been under intense investigation over the last 2 decades. Aberrant canonical Wnt activation has been linked to tumor formation and involves activation of effector molecules or loss of tumor suppressor function. Secreted frizzled-related proteins (sFRPs) are Wnt antagonists. In recent years, accumulating evidence has suggested that sFRPs act as tumor suppressors because their expression is frequently silenced in cancer by promoter hypermethylation. However, sFRPs may also promote cell growth in some contexts. Here, we focus on the known knowledge of sFRPs in tumorigenesis.
Similar content being viewed by others
Article PDF
References
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787–90.
Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279–88.
Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM . Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22: 7218–21.
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118–23.
Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, et al. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003; 63: 4547–51.
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002; 108: 837–47.
Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama SKikuchi A . Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998; 17: 1371–84.
Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu SPolakis P . Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996; 272: 1023–6.
Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066–76.
Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207–10.
Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 1999; 18: 2401–10.
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 1999; 13: 270–83.
Itoh K, Krupnik VESokol SY . Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 1998; 8: 591–4.
Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida MKikuchi A . DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 1999; 19: 4414–22.
Lee JS, Ishimoto A, Yanagawa S . Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem 1999; 274: 21464–70.
Behrens J, von Kries J P, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638–42.
Behrens J, Lustig B . The Wnt connection to tumorigenesis. Int J Dev Biol 2004; 48: 477–87.
Veeman MT, Axelrod JD, Moon RT . A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003; 5: 367–77.
Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141–9.
Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417–22.
Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004; 64: 883–8.
Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 2006; 25: 4116–21.
Kawano YKypta R . Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003; 116: 2627–34.
Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA 1997; 94: 2859–63.
Jones SE, Jomary C . Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 2002; 24: 811–20.
Hoang B, Moos M Jr, Vukicevic S, Luyten FP . Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem 1996; 271: 26131–7.
Wang S, Krinks M, Lin K, Luyten FP, Moos M Jr . Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 1997; 88: 757–66.
Leyns L, Bouwmeester T, Kim SH, Piccolo S, De Robertis EM . Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 1997; 88: 747–56.
Wang S, Krinks M, Moos M Jr . Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts -3A, -5A, or -11. Biochem Biophys Res Commun 1997; 236: 502–4.
Lin K, Wang S, Julius MA, Kitajewski J, Moos M Jr . Luyten FP . The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci USA 1997; 94: 11196–200.
Shirozu M, Tada H, Tashiro K, Nakamura T, Lopez ND, Nazarea M, et al. Characterization of novel secreted and membrane proteins isolated by the signal sequence trap method. Genomics 1996; 37: 273–80.
Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 1997; 94: 6770–5.
Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, et al. SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 1997; 94: 13636–41.
Chang JT, Esumi N, Moore K, Li Y, Zhang S, Chew C, et al. Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum Mol Genet 1999; 8: 575–83.
Bafico A, Gazit A, Pramila T, Finch PW, Yaniv AAaronson SA . Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 1999; 274: 16180–7.
Banyai L, Patthy L . The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-pro-teinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci 1999; 8: 1636–42.
Leach RJ, Banga SS, Ben-Othame K, Chughtai S, Clarke R, Daiger S P, et al. Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25–27, 1996. Cytogenet Cell Genet 1996; 75: 71–84.
Brennan K, Gonzalez-Sancho JM, Castelo-Soccio LA, Howe LR, Brown AM . Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Oncogene 2004; 23: 4873–84.
Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, et al. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 2005; 24: 6323–27.
Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M, et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004; 6: 240–7.
Schmitt JF, Millar DS, Pedersen JS, Clark SL, Venter DJ, Frydenberg M, et al. Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Mol Endocrinol 2002; 16: 213–20.
Ugolini F, Charafe-Jauffret E, Bardou VJ, Geneix J, Adelaide J, Labat-Moleur F, et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001; 20: 5810–7.
Zhou Z, Wang J, Han X, Zhou J, Linder S . Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer 1998; 78: 95–9.
Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, et al. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004; 23: 6672–6.
Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, et al. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci 2004; 95: 741–4.
Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, et al. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 2004; 84: 465–78.
Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, et al. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2005; 116: 584–591.
Clement G, Braunschweig R, Pasquier N, Bosman FTBenhattar J . Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 2006; 25: 3084–92.
Hrzenjak A, Tippl M, Kremser ML, Strohmeier B, Guelly C, Neumeister D, et al. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol 2004; 204: 19–27.
Mandal D, Srivastava A, Mahlum E, Desai D, Maran A, Yaszemski M, et al. Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene 2007; 386: 131–8.
Herman JG, Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–54.
Jones PA, Baylin SB . The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415–28.
Peichel CL, Kozak CA, Luyten FP, Vogt TF . Evaluation of mouse Sfrp3/Frzb1 as a candidate for the lst, Ul, and Far mutants on chromosome 2. Mamm Genome 1998; 9: 385–7.
Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 2005; 65: 9762–70.
Abu-Jawdeh G, Comella N, Tomita Y, Brown LF, Tognazzi K, Sokol SY, et al. Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab Invest 1999; 79: 439–47.
Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003; 201: 204–12.
Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, et al. Expression of sFRP-4 and beta-catenin in human colorectal carcinoma. Cancer Lett 2006; 231: 129–37.
Fukuhara K, Kariya M, Kita M, Shime H, Kanamori T, Kosaka C, et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab 2002; 87: 1729–36.
Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, et al. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 2000; 275: 4374–82.
Han X, Amar S . Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from ceramide-induced apoptosis. J Biol Chem 2004; 279: 2832–40.
Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, et al. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 2000; 19: 4210–20.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was partially supported by a grant from the National Institutes of Health (RO1 CA 093708-01A3), the Larry Hall and Zygielbaum Memorial Trust, and the Kazan, McClain, Edises, Abrams, Fernandez, Lyons & Farrise Foundation.
Rights and permissions
About this article
Cite this article
Shi, Y., He, B., You, L. et al. Roles of secreted frizzled-related proteins in cancer. Acta Pharmacol Sin 28, 1499–1504 (2007). https://doi.org/10.1111/j.1745-7254.2007.00692.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00692.x
Keywords
This article is cited by
-
Aseptic loosening around total joint replacement in humans is regulated by miR-1246 and miR-6089 via the Wnt signalling pathway
Journal of Orthopaedic Surgery and Research (2024)
-
METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2
Cancer Gene Therapy (2023)
-
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Experimental & Molecular Medicine (2020)
-
Study on the SFRP4 gene polymorphism and expression in prostate cancer
Journal of Genetics (2020)
-
SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
Cancer Cell International (2020)